Evaluation of the BHX Implant in Children with a BAHS
Launched by OTICON MEDICAL · Nov 12, 2018
Trial Information
Current as of September 04, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients who have decided to undergo a Bone Anchored Hearing Surgery and receive a Ponto system.
- • 2. Signed informed consent.
- • 3. Patients between 5 - 16 years of age.
- • 4. Patients eligible for one stage surgery.
- • 5. Patients who have been using Ponto sound processor on a soft band for at least 2 weeks.
- Exclusion Criteria:
- • 1. Patients who cannot attend follow up visits.
- • 2. Patients with single side deafness (SSD).
- • 3. In surgeon's opinion, any other disorder and condition that may deem the patient unfit to participate in the study.
- • 4. Patients who receive other implant than the Ponto BHX.
- • -
About Oticon Medical
Oticon Medical is a leading global innovator in the field of hearing solutions, dedicated to improving the quality of life for individuals with hearing loss. As a subsidiary of the well-established Oticon brand, Oticon Medical specializes in the development and manufacture of advanced auditory devices, including bone-anchored hearing systems and implantable solutions. Committed to research and development, the company actively sponsors clinical trials to evaluate the efficacy and safety of its products, ensuring that cutting-edge technology continues to meet the evolving needs of patients and healthcare professionals. With a focus on evidence-based practices, Oticon Medical strives to enhance auditory experiences and foster better communication for those affected by hearing impairment.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Middlesbrough, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials